By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Panelists generally agreed that Goldman Sachs' earnings are cyclical and its valuation is rich, but they differed on whether the current multiple is a discount or a trap. The key debate centered around the impact of Basel III endgame capital requirements on ROE and the extent to which the current multiple already prices in tighter capital rules.
Risk: Increasing risk-weighted asset (RWA) density due to Basel III endgame capital requirements could structurally suppress ROE and compress the current multiple.
Opportunity: Goldman Sachs' growing asset-management and wealth fees could offset higher capital charges and reduce earnings volatility.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Is GS a good stock to buy? We came across a bearish thesis on The Goldman Sachs Group, Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bears’ thesis on GS. The Goldman Sachs Group, Inc.'s share was trading at $1,032.01 as of June 9th. GS’s trailing and forward P/E were 18.85 and 17.54 respectively according to Yahoo Finance.
Nonwarit/Shutterstock.com
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals in the Americas and internationally. GS is being framed as a mid-teens ROE compounder, but the underlying earnings power appears significantly weaker once non-recurring items and capital actions are adjusted for. The reported mid-teens return on equity is inflated by cyclical mark-to-market gains and periodic reserve releases, both of which are inherently volatile and not representative of sustainable fee-based earnings.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
At the same time, aggressive share repurchases have mechanically supported headline profitability by reducing equity, further masking the softness in core operating performance. Goldman Sachs’ exit from its Marcus consumer platform underscores the failure of its diversification push, with capital-intensive ambitions in retail lending ultimately proving value-destructive and strategically misaligned.
Stripped of these elements, the core franchise is increasingly concentrated in highly cyclical investment banking and trading activities, where earnings are far less predictable across economic cycles. This cyclicality raises concern that the market is overstating the durability of current profitability, particularly as benign capital markets conditions may not persist. If mark gains normalize lower and buyback support diminishes, reported returns could compress rapidly toward high single-digit levels, revealing a materially lower earnings base.
Against this backdrop, the market appears to be pricing in an overly stable earnings trajectory that is inconsistent with Goldman Sachs’ historical sensitivity to market cycles. The setup implies downside risk to valuation, with a bearish price target of $709 reflecting normalization of returns and fading cyclical tailwinds. Overall, the thesis suggests Goldman Sachs’ headline profitability is cyclical rather than structural, leaving earnings and valuation vulnerable as conditions normalize further.
Four leading AI models discuss this article
"Goldman’s valuation is currently pricing in a sustained volatility premium that makes the stock a hold rather than a buy at these levels."
The bearish thesis correctly identifies that GS’s ROE (Return on Equity) is flattered by capital structure engineering, but it misses the pivot in Goldman’s business mix. While the Marcus failure was a strategic embarrassment, the firm has successfully doubled down on its core strengths: high-margin M&A advisory and FICC (Fixed Income, Currencies, and Commodities) trading. Trading at 17.5x forward P/E is rich for a cyclical bank, but the market is pricing in a 'higher-for-longer' volatility regime which historically benefits Goldman’s trading desk. The $709 price target is overly punitive, assuming a reversion to a low-growth, low-volatility environment that ignores the firm's dominant market share in primary issuance.
The bear case is right that if global capital markets activity stalls due to a liquidity crunch, GS lacks the stable, deposit-heavy retail moat of a JPMorgan, leaving it with nowhere to hide.
"GS is cyclically cheap, not structurally overvalued—but the article is right that downside to $700s is real if IB pipelines weaken and buybacks slow."
The bearish thesis conflates cyclicality with overvaluation—a common error. Yes, GS earnings are cyclical; that's priced into a 17.54x forward P/E, which is below the S&P 500 average (~20x) and below historical GS multiples. The article correctly identifies mark-to-market gains and buybacks as earnings tailwinds, but doesn't quantify their magnitude or whether they're already embedded in consensus estimates. Marcus was a strategic mistake, but it's already behind GS; the real question is whether core IB/trading franchises are sustainably profitable at current spreads. At $1,032, GS trades near tangible book value (~$140/share = ~7.4x), offering downside protection if cyclical compression occurs. The $709 target assumes normalized ROE compression to 8-9%, but doesn't justify why that's the floor.
If capital markets remain active (Fed cuts, M&A rebound, volatility-driven trading), GS's cyclical earnings could sustain 15%+ ROE for 2-3 years, making today's valuation cheap; the article assumes normalization without modeling the bull case for sustained benign conditions.
"GS's prime brokerage and post-Marcus capital redeployment provide more earnings durability than the bear case allows for."
The bear thesis correctly flags GS's earnings sensitivity to trading and IB cycles but glosses over two offsets: GS's prime brokerage and equities franchise has shown durable share gains even in flat markets, and the Marcus exit frees roughly $10B+ in capital for higher-ROE uses. At 17.5x forward earnings the stock already embeds some normalization; a $709 target requires both mark-to-market gains to vanish and buybacks to stop entirely. Regulatory capital rules and potential rate-cut driven ECM rebound are omitted variables that could stabilize ROE near 13-14%.
If capital markets volumes contract sharply in 2025 and GS fails to redeploy freed capital at mid-teens returns, the normalized ROE could indeed drop to high single digits faster than the market anticipates.
"GS has durable earnings power due to a mix of fee-based businesses and capital efficiency that can sustain profits even if cycles soften."
Despite the bears’ cyclicality critique, GS isn’t a pure investment bank/trading shop. It has sizable asset-management and private wealth franchises that deliver steadier, fee-based revenue, reducing earnings volatility. Buybacks still boost EPS, and the Marcus exit removes some retail risk while focusing capital deployment on core franchises. In a backdrop of resilient capital markets and reasonably constructive rates, mid-teens ROE can persist, supporting a multiple near 17.5x forward. Valuation isn’t compelling on a if-everything-stays-perfect basis, but the earnings mix offers ballast that the article underplays, making downside risk asymmetric rather than decisive.
But a sharp macro shock could erase trading volumes and NII gains quickly, and GS’s decision to exit Marcus may have reduced longer-run fee growth opportunities more than the article implies.
"Basel III capital requirements will structurally compress ROE, making current P/E multiples unsustainable regardless of market volatility."
Claude, your focus on tangible book value is misleading for a bank that relies on trading velocity rather than balance sheet lending. GS's valuation is driven by ROE, not book value, and that ROE is highly sensitive to Basel III endgame capital requirements. Nobody mentioned that the impending increase in risk-weighted asset (RWA) density will structurally suppress ROE regardless of market volatility. If capital charges rise, the current 17.5x multiple is a trap, not a discount.
"RWA density is a real headwind, but the market's pricing of it—and GS's regulatory influence—remains unclear from this discussion."
Gemini's RWA density point is material but overstated. Basel III endgame hasn't finalized; current proposals suggest ~3-5% RWA inflation for GS, not structural ROE collapse. More pressing: nobody quantified how much of the 17.5x multiple already prices in tighter capital rules. If it does, Gemini's 'trap' thesis weakens. If it doesn't, that's a real bear catalyst. The article also ignores that GS lobbied hard on endgame—regulatory outcomes aren't predetermined.
"GS's fee-based businesses can blunt the ROE impact of modest RWA inflation that Gemini treats as decisive."
Gemini overstates the Basel III trap by treating RWA density as an unavoidable ROE suppressor without addressing how GS's growing asset-management and wealth fees can offset higher capital charges. Those steadier revenues reduce the earnings volatility that makes trading-driven ROE so sensitive to regulatory shifts. If final rules stay near the 3-5% range Claude cited, the multiple already embeds that adjustment rather than pricing a structural collapse.
"Regulatory drag from Basel III endgame could persist and erode GS's ROE, implying today's 17.5x multiple may compress more than the market currently anticipates if RWA inflation proves larger or stickier than assumed."
Gemini's claim that Basel III endgame is a non-event misses the path risk: even 3-5% RWA inflation would pressure ROE, and the market likely already prices some of that in; but if negotiations tilt toward higher RWA or tougher capital rules, the multiple could compress further. The risk isn't a one-off; it's regulatory drift that could linger for years, capping upside. This nuance about timing and durability deserves emphasis when you claim a 'trap' is unlikely.
Panelists generally agreed that Goldman Sachs' earnings are cyclical and its valuation is rich, but they differed on whether the current multiple is a discount or a trap. The key debate centered around the impact of Basel III endgame capital requirements on ROE and the extent to which the current multiple already prices in tighter capital rules.
Goldman Sachs' growing asset-management and wealth fees could offset higher capital charges and reduce earnings volatility.
Increasing risk-weighted asset (RWA) density due to Basel III endgame capital requirements could structurally suppress ROE and compress the current multiple.